고객센터
찾아오시는길

HOME > 회원마당 > 보도자료보도자료

개의 줄기세포 소스; 지방, 골수, 난자

미래 | 2018.10.01 11:00 | 조회 31043
September 18, 2018

Preferred Sources for Isolating Stem Cells in Dogs

A recent article reviewed potential tissue sources and applications for stem cell use in veterinary patients.
By Natalie Stilwell, DVM, MS, PhD
stem cell therapyStem cell research has increased significantly in human medicine over the past 20 years, and stem cells derived from sites including bone marrow and adipose tissue are now widely used to treat various diseases. Comparatively, stem cell therapy has been explored minimally in veterinary medicine. Researchers at the Konkuk University’s Center for Stem Cell Research in South Korea recently provided a reviewof mesenchymal stem cell (MSC) therapy in animals.

RELATED: 

Mesenchymal Stem Cells

MSCs differ from hematopoietic stem cells in that they can differentiate into osteoblasts, adipocytes, cardiomyocytes, chondrocytes, hepatocytes, and stem cells. MSCs can be isolated from the following adult, neonatal, and fetal tissues:
  • Bone marrow
  • Adipose tissue
  • Heart
  • Peripheral blood
  • Dermis
  • Umbilical cord blood (UBC)
  • Placenta
  • Amniotic fluid

MSC implantation has been explored for the treatment of a variety of disorders in animals, including atopic dermatitis, osteoarthritis, chronic kidney disease, spinal cord injury, and skin wounds. According to the study authors, an important next step is to determine an ideal tissue source for high yield of MSCs.
 

Umbilical Cord Blood

Collection of MSCs from UCB has been explored primarily in humans, sheep, and horses. Relatively few studies have examined UCB-MSC use in pet animals, including dogs.

While collecting UCB is noninvasive and associated with low morbidity, this source yields significantly fewer MSCs compared with other tissues, such as bone marrow. Human studies showed that UCB-MSC isolation into cell culture media had a low estimated success rate of 26%, but the likelihood of successful isolation relied heavily on obtaining sufficient blood volume. Similarly, UCB-MSC yield in horses, goats, and sheep reportedly increases with increasing blood volume. While some canine studies have successfully isolated MSCs from UCB volumes as low as 8 mL, the authors of the current study reported an average yield of only 1 mL of UCB with a 66% success rate for MSC isolation. Thus, UCB may prove to be an unreliable source of stem cells in canine subjects.

Another important consideration is that UCB can only be obtained during C-section in the dog, as the bitch typically consumes the placenta and umbilical cord during natural birth. While 1 study reported higher MSC yields from fetal heart tissue, this method is more invasive and raises ethical concerns. Therefore, the authors stated that alternative options to neonatal and fetal tissues should be explored.
 

Adipose and Reproductive Tissues

Adipose tissue can also be used for MSC collection, as cells from this source can differentiate into adipogenic, osteogenic, and chrondrogenic types. Interestingly, reproductive tissues also yield high numbers of MSCs. Although ovaries and testes are frequently discarded as medical waste during sterilization, both tissues are “proven to be potent and reliable sources of MSCs,” according to the authors. Both also have the same multipotent potential as do adipose-derived MSCs. Therefore, the authors recommended future use of reproductive and adipose tissues, rather than UCB, for MSC collection in veterinary medicine.   

 
Dr. Stilwell received her DVM from Auburn University, followed by a MS in fisheries and aquatic sciences and a PhD in veterinary medical sciences from the University of Florida. She provides freelance medical writing and aquatic veterinary consulting services through her business, Seastar Communications and Consulting.

Sign up to receive the latest news in veterinary medicine.
보도자료
번호 제목 글쓴이 조회 날짜
943 “줄기세포 이용한 황반변성 치료 가능성 열려” 관리자 1689 2025.05.22
942 ‘유전자 가위’로 문제 DNA 찾아내 ‘싹둑’, 희귀질환 아기 살렸다 관리자 493 2025.05.19
941 “세포 치료, 개원의에도 기회 줘야” 김응석 1535 2025.03.05
940 줄기세포 배양 기술, 심부전 환자들에게 새 희망 열다 관리자 3987 2025.02.12
939 IT·과학 “수명 늘리러 우주로 갑니다”…무중력 상태서 의료 신기술 만든.. 관리자 1225 2024.12.17
938 치매 환자의 새로운 희망, 줄기세포로 치료 가능성 열다 관리자 4987 2024.12.13
937 부산시 특사경, 줄기세포 화장품 등 부당 광고업체 11곳 적발 이희영 4450 2024.10.11
936 ‘줄기세포 배양부터 치료 증례까지’ 벳스템솔루션 10월 28일 세미나 이희영 4546 2024.10.11
935 대한 줄기세포 치료학회 추계학술대회 성황리 성료 관리자 4314 2024.10.10
934 배양육 미팅이었고 주로 세포 배양 오가노이드 대체육 등 이희영 1773 2024.10.10
933 자가iPS당뇨치료; 인슐린생산 증가 가능; 자가세포가 중요함 이희영 1858 2024.10.04
932 당뇨치료에 대한 메타분석 결과; 가능성이 높다 이희영 1160 2024.10.04
931 신장 재생 Lrig 1 마커 이희영 1288 2024.08.21
930 답글 마커의 유무가 중요한 것 같습니다 그러나... 이희영 1330 2024.08.21
929 유방암 보형물에서 배양 지방줄기세포 사용 이희영 5292 2024.08.21
928 답글 좋은 시도인데 배양이 필요하네요 이희영 1631 2024.08.21
927 이건 제 글입니다; 규제완화 요망 이희영 1293 2024.08.21
926 연세사랑 고용곤원장; 규제완화 요망 이희영 1200 2024.08.21
925 답글 배양을 강조하시니 감사하네요 이희영 1465 2024.08.21
924 뇌 조직 직접 대체 시도; 곧 인간에게도 적용할 것 같습니다. 이희영 1534 2024.08.20